Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL in Patients With Chronic Shift Work Sleep Disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2010
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary) ; Modafinil (Primary)
- Indications Circadian rhythm sleep disorders
- Focus Registrational; Therapeutic Use
- Sponsors Cephalon
- 07 Oct 2006 New trial record.